1-2 of 2
Peter Hu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Continuous Subcutaneous Insulin Infusion (CSII) of Insulin Aspart Versus Multiple Daily Injection of Insulin Aspart/Insulin Glargine in Type 1 Diabetic Patients Previously Treated With CSII

Free
Irl B. Hirsch, MD, Bruce W. Bode, MD, Satish Garg, MD, Wendy S. Lane, MD, Allen Sussman, MD, Peter Hu, PhD, Olga M. Santiago, MD, Jerzy W. Kolaczynski, MD, for the Insulin Aspart CSII/MDI Comparison Study Group
Journal: Diabetes Care
Diabetes Care 2005;28(3):533–538
https://doi.org/10.2337/diacare.28.3.533
Published: 01 March 2005
View articletitled, Continuous Subcutaneous Insulin Infusion (CSII) of Insulin Aspart Versus Multiple Daily Injection of Insulin Aspart/Insulin Glargine in Type 1 Diabetic Patients Previously Treated With CSII
Open the PDF for Continuous Subcutaneous Insulin Infusion (CSII) of Insulin Aspart Versus Multiple Daily Injection of Insulin Aspart/Insulin Glargine in Type 1 Diabetic Patients Previously Treated With CSII in another window
Journal Articles

Initiating Insulin Therapy in Type 2 Diabetes : A comparison of biphasic and basal insulin analogs

Free
Philip Raskin, MD, Elsie Allen, MD, Priscilla Hollander, MD, Andrew Lewin, MD, Robert A. Gabbay, MD, PHD, Peter Hu, PHD, Bruce Bode, MD, Alan Garber, MD, for the INITIATE Study Group
Journal: Diabetes Care
Diabetes Care 2005;28(2):260–265
https://doi.org/10.2337/diacare.28.2.260
Published: 01 February 2005
View articletitled, Initiating Insulin Therapy in Type 2 Diabetes : A comparison of biphasic and basal insulin analogs
Open the PDF for Initiating Insulin Therapy in Type 2 Diabetes : A comparison of biphasic and basal insulin analogs in another window